Shares of ALK-Abelló A/S (OTC:AKBLF – Get Free Report) shot up 0.2% on Wednesday . The company traded as high as $33.05 and last traded at $33.05. 100 shares were traded during trading, a decline of 67% from the average session volume of 300 shares. The stock had previously closed at $33.00.
ALK-Abelló A/S Stock Performance
The business’s 50-day moving average price is $30.52 and its two-hundred day moving average price is $28.55.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Featured Articles
- Five stocks we like better than ALK-Abelló A/S
- Best Stocks Under $10.00
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Insider Buying Explained: What Investors Need to Know
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- What is a Dividend King?
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
